Smooth pursuit eye EP0041 * movements Adaptive tracking EP0041 Effect on Number N01066 * task N01066 * Effect on Choice Reaction Time N01079 Effect on Tapping Test N01066 * Effect on ARCI 49 N01066 * N01069 N01118 * N01079 * N01295 * Effect on Bond and N01066 Lader’s VAS N01067 * N01118 EP0041 * N01079 N01066 * N01295 * Effect on N01069 § * Pharmacodynamic EEG Effect on Neurological Assessments N01067 * N01118 * EP0041 Visual verbal learning EP0041 test N01129 * Essential tremor N01162 * Post-herpetic neuralgia N01187 * Myoclonus of ULD N01236 * Myoclonus of ULD PD levetiracetam CL0027 § Interactions ethanol EP0041 Population PD Healthy subjects and PK-PD analyses Target population CL0027 * * Indicates the primary aim of the study. § Subjects who would be eligible to receive the drug if approved for the proposed indication. And adolescents if applicable. ‡
Smooth pursuit eye movements Adaptive tracking Effect on Number task Effect on Choice Reaction Time Effect on Tapping Test Effect on ARCI 49 Effect on Bond and Lader’s VAS Effect on Pharmacodynamic EEG Effect on Neurological Assessments Visual verbal learning test Essential tremor Post-herpetic neuralgia Myoclonus of ULD Myoclonus of ULD EP0041 EP0041 N01066 N01066 N01079 N01066 N01066 N01069 N01118 N01079 N01295 N01066 N01067 N01118 EP0041 N01079 N01066 N01295 N01069 § N01067 N01118 EP0041 EP0041 N01129 N01162 N01187 N01236 * * * * * * * * * * * * * * * * * * * PD Interactions levetiracetam CL0027 § ethanol EP0041 Population PD and PK-PD analyses Healthy subjects Target population CL0027 * * Indicates the primary aim of the study. § Subjects who would be eligible to receive the drug if approved for the proposed indication. ‡ And adolescents if applicable.
auspar-brivaracetam-170307.docx